NBA

RANBAXY - enters anti-AIDS segment

The anti-AIDS drug market is currently dominated by the Mumbai based Cipla. Presently, Ranbaxy laboratories, the country's largest pharmaceutical company, is planning to enter the anti-AIDS drugs segment. According to Ranbaxy's regional director for India and west Asia, S D Kaul, the company is in a position to launch Lamivudine, Nevirapine, Aabacavir and Indinavir products in the Indian...

Ranbaxy joins hand with Cipla to co-market ciprofloxacin

Two of the leading pharmaceutical industries, Ranbaxy Laboratories and Cipla announced an alliance to co-market Ranbaxy’s once-a-day formulation of Ciprofloxacin. The formulation had recently received Drug Controller General of India’s (DCGIs) approval for marketing in India. Ciproloxacin is a unique dosage form of the broad-spectrum antibiotic. The domestic market for ciprofloxacin is es...

Ranbaxy trying to make inroads in herbal drugs market

Ranbaxy Laboratories Chairman, Tajendra Khanna, in a recent seminar organised by Guru Gobind Singh Indraprastha University on 'Managing Corporate Reputation', spoke about the comapny's plan of foraying into the herbal drugs market. He said that their products would create stiff competition for the key player in the market - Dabur, which has 60 per cent market share. The company plans to m...

Ranbaxy gets US FDA approval for Lisinopril

Ranbaxy Pharmaceuticals Inc (RPI) has received a tentative approval from the US FDA for Lisinopril tablets. Lisinopril is recommended for hypertension, either alone for initial therapy or with other classes of anti-hypertenive agents. It is also used as adjunctive therapy in the management of heart failure and patients who do not respond to diuretics. // However it expects to launch...

Ranbaxy Labs' Entry Into Anti-Acne Market

Ranbaxy Laboratories' entry into the global anti-acne market is likely to be delayed as the mandatory inspection by the US Food and Drug Administration (US FDA) for the company's ANDA (Abbreviated New Drug Application) for the generic isotretinoin has been postponed. The US FDAs investigator had not yet arrived. The US FDA has already approved its manufacturing facility for the produc...

Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA

Ranbaxy Laboratories (RL) has received its first tentative approval from the US Food and drug administration ( FDA ) to manufacture // and market lamivudine tablets that can be used in combination with other anti - retroviral agents (ARVs) to treat patients with HIV infection. The approval has come after a number of quality checks and inspections by some of the most stringent agencies...

Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart

In a statement released by Ranbaxy Pharmaceuticals Inc (RPI), they have stated that have received the prestigious Supplier Award // from Wal-Mart, the largest chain store in the US, for outstanding performance in the first quarter of 2005. Wal-Mart Stores is a global company with more than 1.3 million associates worldwide and nearly 5,000 stores and wholesale clubs across 10 countries....

Ranbaxy opens Drug discovery centre in Gurgaon

Ranbaxy, Pharmaceutical Company has opened up its third state of the art drug discovery research centre in Gurgaon which was inaugurated by President A.P.J. Abdul Kalam on 16th August 2005. The new R&D centre will focus on new drug // discovery research and the development functions of medicinal chemistry, analytical development, pharmacology, molecular technologies, infectious diseases,...

Ranbaxy Laboratories All Set To Export Bird Flu Vaccines

In view, of the ever-increasing threat about bird flu worldwide, there has been a healthy competition among several pharmaceutical companies to manufacture the drug.// Ranbaxy Laboratories has become the first Indian company to start shipments of generic version of bird flu drug, Tamiflu. The drug is believed to get shipped to a country where the patent held by the Swedish major Roche wou...

SRL Ranbaxy offers quicker bird flu diagnostic test

SRL Ranbaxy, a pathology laboratory network promoted by India's pharma major Ranbaxy Laboratories, Monday announced the launch of the first diagnostic// test for bird flu that can give results in just a day. "A first of its kind, it is the only diagnostic test for bird flu that can be effectively employed for mass screening and gives accurate results within just one day vis-à-vis two to...

Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu

New Delhi: SRL Ranbaxy has introduced a diagnostic test for Bird Flu that will enable mass-screening, and has the capability to report near accurate results within 24 hours. Named as RT-PCR test, // this test boasts of being powerful where the results will be available in a day. Certainly a blessing in the event of an outbreak. The tests that are presently available to check for Bird F...

Ranbaxy Launches Once-a-day Inhaler For Asthma Patients

Indian pharmaceutical major Ranbaxy Laboratories Limited Friday announced the launch of a branded once-a-day inhaler for asthma patients//. "Ranbaxy has introduced this product for the first time in India. Osonide is available in HFA (Hydroxy fluoro Alkane: the propellant) based pressurised metered dose inhalers in two strengths - Osonide 160mcg and Osonide 80mcg," the company said in...

Ranbaxy Expands By Acquiring A Generic Company In Belgium

Indian pharmaceutical company Ranbaxy Laboratories Ltd., announced on Thursday about its overseas expansion of acquiring a generics company, Ethimed NV of Belgium. // This is the fourth acquisition announced by the company in a week. The earlier ones included the takeover of Romania's Terapia for $324 million, GlaxoSmithKline Plc's Italian generic business and the purchase of the rights...

Ranbaxy Acquires Glaxosmithkline's Generic Unit in Spain

Looking to expand its presence and product portfolio in the Spanish market, pharma major Ranbaxy Laboratories Ltd today said it has acquired GlaxoSmithKline's Mundogen generic business in Spain. // Ranbaxy's CEO and MD Malvinder Mohan Singh said that the acquisition was in line with the company's M&A strategy to focus on the EU markets. The company said in a filing with the...

Ranbaxy Signs Licensing, Supply Agreement for Canadian Market

India's biggest drugmaker Ranbaxy Laboratories Ltd today said it had entered into a licensing and supply agreement with Janssen-Ortho Inc (JOI) for a generic version of Risperidone compressed tablets in the Canadian market. // The agreement was signed between Ranbaxy's wholly owned subsidiary, Ranbaxy Pharmaceuticals Canada Inc (RPCI) and Janssen-Ortho Inc (JOI), the company said in a...

Ranbaxy's Four HIV/AIDS Drugs In WHO Pre-Qualification List

India's biggest drug maker Ranbaxy Laboratories Limited today said the World Health Organistion has included four of its additional Anti Retro- Viral (ARV) products in its pre-qualification list. // The products approved by WHO are Efavirenz 600mg tablets, Efavirenz 200mg capsules, Stavudine 30mg capsules, Stavudine 40mg capsules, the company said in a statement. "This is a...

Ranbaxy In-Licences NDDS Analgesic Molecule From Ethypharm

Ranbaxy Laboratories Limited today entered into an in-licensing agreement with Ethypharm S.A., France for novel drug delivery system (NDDS) analgesic // , Tramadol in the Indian market The agreement was signed with Ethypharm LL India (Ethypharm), the wholly-owned subsidiary of the French drug major for 50 mg strength, the company said in a statement. The product will be supplied from E...

Ranbaxy Gets USFDA Approval For Doxycycline Tablets

Ranbaxy Laboratories Ltd has received approval from USFDA for manufacturing and marketing Doxycycline Tablets in the US market.// The company informed the Bombay Stock Exchange that it got the approval for marketing the antibiotic in strengths of 50mg, 75mg and 100mg. Doxycycline is indicated for a variety of infections caused by susceptible strains or micro-organisms inclu...

Ranbaxy Signs Agreement With Zenotech For Cancer Drugs

Pharma major Ranbaxy Laboratories Ltd today said its wholly owned subsidiary Ranbaxy Pharmaceuticals Inc (RPI) has signed an agreement //with Hyderabad-based Zenotech Laboratories Ltd to market generic cancer drugs in the US and Canada. Under the agreement, Zenotech Labs would develop, submit for regulatory approval and manufacture a total of 11 oncology products. Ranbaxy would market...

Ranbaxy Ties Up With US Co For Mktg Zonisamide Capsules

Pharma major Ranbaxy Laboratories Ltd has entered into a strategic partnership with US-based Invagen Pharmaceuticals Inc for marketing Zonisamide Capsules // , which are used for the treatment of epilepsy, in the US market. Under the agreement products would be developed and submitted for approval to the USFDA. Ranbaxy Pharmaceuticals Inc would market the products under the the company...

NBA To Distribute HIV/AIDS Materials In China

The National Basketball Association of the US has teamed up with the UN's Children's Fund to distribute education materials and sports kits on HIV/AIDS //to schools in seven provinces of China. Dubbed as 'Skills for Life in a Box,' the kits contain interactive HIV/AIDS learning materials for teachers and peer educators to use in the classroom. Each kit also contains a bask...

Ranbaxy Gets USFDA Nod For Simvastatin

Pharma major Ranbaxy Laboratories Ltd has received approval from the USFDA for manufacturing and marketing cholesterol-lowering Simvastatin Tablets in the US market. // The company said it has received the approval for marketing the drug in strengths of 80mg with 180 day exclusivity. Simvastatin, currently marketed as 'Zocor' in the US, has been found to be bioequivalent b...

Ranbaxy Launches Clarithromycin, Terbinafine Tablets in Japan

Ranbaxy Laboratories Ltd today said Nihon Pharmaceutical Industry Ltd, a joint venture between the company and Japan-based Nippon Chemiphar Ltd // , has launched the antibiotic 'Clarithromycin' and anti-fungal 'Terbinafine' tablets in the Japanese market. Clarithromycin has been launched in strengths of 50mg, 200mg and Terbinafine of 125mg. The products have a market size of around 4...

Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr

Zenotech Laboratories Ltd today said it will issue 20 lakh equity shares to Ranbaxy Laboratories on a preferential basis for Rs 20 crore. // The board of directors has approved the issue of 20 lakh equity shares of Rs 10 at a price of Rs 100 on a preferential basis to Ranbaxy, subject to shareholders' approval, the company informed the Bombay Stock Exchange. The board also...

Ranbaxy, Aurobinda Pharma Applauded by Annan

India's Ranbaxy Laboratories and Aurobinda Pharma were among some of the world's leading pharmaceutical and diagnostic companies applauded by UN Secretary General Kofi Annan // for their commitment to expand access to HIV/AIDS treatment and prevention. Annan complimented these companies for their efforts in the field of HIV/AIDS treatment and prevention after a meeting with their top...

Ranbaxy Launches Asthma Inhalation Capsule in India

Pharma major Ranbaxy Laboratories Ltd Tuesday launched its branded inhalation capsules in India for the treatment of asthma//. A unique combination of long acting Beta2-agonist Formoterol and the most potent inhaled corticosteroid Fluticasone, the inhalation capsule Avessa is available as Rheocaps Avessa 100 mcg, Avessa 250 mcg, Avessa 500 mcg, depending on the severity of Asthma. <b...

NBA To Usher In Standardized Heart Testing

New York: NBA has geared up to institute mandatory heart testing that will follow a standardized screening procedure, for every person in the league.// After the death of Atlanta Hawks center Jason Collier, NBA has got its act together to prevent such incidents in the future. The mandated tests will include the gamut of physical examination, blood work, an electrocardiogram, a resting ech...

Ranbaxy To Market Pain Killer In Canada

Ranbaxy Pharmaceuticals Canada Inc. (RPCI), the wholly owned subsidiary of Indian pharma major Ranbaxy Laboratories Limited (RLL), has entered// into a tie-up with Janssen-Ortho Inc. (JOI) for marketing of its generic painkiller Fentanyl in Canada. The second product to be commercialised by RPCI, Fentanyl would be sold under Ranbaxy's label RAN under the licensing and supply agreement wi...

Ranbaxy to Market Debiopharm's New Drug in India

Indian pharma major Ranbaxy Laboratories Limited has signed an exclusive licensing agreement with Swiss biopharmaceutical development company Debiopharm Group to// market its new gastro-enterology drug. Debiopharm's new drug Sanvar, an injectable molecule, is for treatment of acute variceal bleeding and prevention of rebleeding related to portal hypertension, Ranbaxy said in a stateme...

Ranbaxy Gets FDA Approval for Depression Drug

India's drug major Ranbaxy Laboratories has received the US Food and Drug Administration (FDA)'s final approval to manufacture// and market its formulation for the treatment of major depressive disorders in adults. Ranbaxy Pharmaceuticals Inc. (RPI), a wholly-owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced Friday that FDA approval permitted the Indian company to make...

Prestigious Wilson Award Goes To Yale Cell Biologist Joel Rosenbaum

Joel Rosenbaum, professor in the Department of Molecular, Cellular and Developmental Biology (MCDB) and faculty member at Yale since 1967, will be awarded// the prestigious 2006 E. B. Wilson Medal, the American Society for Cell Biology’s highest honor for scientific research in cell biology. The medal is indeed a recognition of Rosenbaum’s contribution on the assembly, maintenance an...

Ranbaxy Laboratories to Be Aided in Drug Research

The department of science and technology will provide soft loans to pharmaceutical major Ranbaxy// Laboratories to develop new drugs and carry out clinical trials, the company said Monday. Under the pact with the department, which is under the science and technology ministry, Ranbaxy will undertake research for development of therapeutic drugs for anti-infective and inflammation proble...

Ranbaxy Gets FDA Approval for Hypertension Drug

Indian pharma major Ranbaxy Laboratories Limited has received the approval from the US Food and Drug //Administration (FDA) to manufacture and market generic hypertension drug Atenolol in the country. Ranbaxy plans to market Atenolol tablets of 25 mg, 50 mg, and 100 mg dosage manufactured by Mumbai-based Ipca Laboratories in the US from the first quarter of 2007, the company said in a...

Ranbaxy in Fray to Buy Merck's Generic Drugs Unit

Davos: After six global acquisitions last year, India's Ranbaxy Laboratories has entered the market again to acquire the generic drugs business of German// pharmaceuticals major Merck in a deal estimated at over $5 billion. ‘We are in talks with private equity funds to finance the deal,’ Ranbaxy's chief executive Malvinder Singh said on the margins of the annual meeting of the World E...

Ranbaxy Gets FDA Approval for Insomnia Drug

Indian drug major Ranbaxy Laboratories Ltd says it has obtained tentative approval from the US Food and Drug Administration to manufacture// and market a drug for insomnia. The US unit of the company announced Friday that the Office of Generic Drugs, US FDA, has determined the Ranbaxy formulations of Zolpidem Tartrate tablets to be bioequivalent and to have the same therapeutic effect...

Ranbaxy Develops New Compound for Respiratory Inflammation

Indian generics major, Ranbaxy Laboratories Limited has achieved a significant milestone in its collaboration with GSK.// The company’s New Drug Discovery Research (NDDR) team has finished the development of a new compound for respiratory inflammation. As per the recently signed multi-year agreement signed between the two companies in 2003, Ranbaxy will further profile thi...

Sunbathers Beware of Skin Cancer, Dermatologists Warn

People might choose to hit beaches during summer in the West, but experts warn of skin cancer . "Enjoy it, but enjoy it in moderation and with common sense," said Dr. Warren Heymann, head of the division of dermatology at Cooper University Hospital in Camden. If you're going to be outside, try to stay out of the midday sun, stay in the shade, wear appropriate clothing," use...

FDA Approves Ranbaxys Allergy Drug

India's drug major Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market a pill to treat rhinitis, one of the most common illnesses in the US. Affecting more than 50 million people in US, rhinitis is marked by bouts of sneezing and itching, or a runny or stuffy nose that do not seem to go away. Total an...

Ranbaxy Launches Pravastatin Sodium Tablets in US

Mumbai, June 25 (IANS) Indian pharmaceutical major Ranbaxy Laboratories Ltd Monday said it had launched in the US pravastatin sodium tablets, meant for heart diseases . Being the first-to-file, the company will enjoy a 180-day exclusivity for the pravastatin 80mg and benefit from the commercial gains during the period, it informed the Bombay Stock Exchange (BSE). The a...

Ranbaxy Labs Extends Roots in South Africa

In line with Ranbaxy Laboratories aggressive international expansion strategy, the approval from South Africa's Competition Commission has solidified the acquisition of Be-Tabs Pharmaceuticals (Pty) Limited ("Be-Tabs") by Ranbaxy Laboratories. (RNBV). The deal is valued at R500 million (USD 70 Million) and will make Ranbaxy the fifth largest generic pharmaceutical company in South...